Navigation Links
Medivir Announces TMC435 in an Expanded Clinical Collaboration
Date:4/18/2012

study comparing TMC435 versus telaprevir, each in combination with Pegylated Interferon α-2a (PegINF) and ribavirin (RBV), in hepatitis C genotype-1 infected patients who were null or partial responders to prior PegINF/RBV therapy
  • TMC435-C3011 is an open label, single arm phase III trial to explore the efficacy, safety and tolerability of TMC435 150 mg once daily, in combination with PegIFN/RBV in 100 treatment naïve or treatment experienced, hepatitis C genotype-4 infected patients  

  • For additional information from these studies, please see http://www.medivir.com and http://www.clinicaltrials.gov

    About Hepatitis C

    Hepatitis C is a blood-borne infectious disease of the liver and is a leading cause of chronic liver disease and liver transplants. The World Health Organization estimates that nearly 180 million people worldwide, or approximately 3% of the world's population, are infected with hepatitis C virus (HCV). The CDC has reported that almost three million people in the United States are chronically infected with HCV.

    About Medivir

    Medivir is an emerging research-based specialty pharmaceutical company focused on the development of high-value treatments for infectious diseases. Medivir has world class expertise in polymerase and protease drug targets and drug development which has resulted in a strong infectious disease R&D portfolio. The Company's key pipeline asset is TM
    '/>"/>

    SOURCE Medivir
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Medivir: R&D Day
    2. Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
    3. CardioInsight Announces Appointment of Jim Bullock as Chairman of the Board of Directors
    4. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
    5. Custom Spine Announces 510K Clearance for Securis Cannulated Screw System
    6. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
    7. Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology
    8. ADVENTRX Announces Establishment of Regulatory Advisory Board
    9. Genesis Biopharma Announces Proposed Public Offering of Common Stock and Warrants
    10. Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer
    11. GenVec Announces Research on Improved Vaccine Vectors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/30/2015)... , June 30, 2015  Custom Computer Specialists, ... today that they are silver sponsors of the Primary ... PCDC sponsor, Custom is lending their support of PCDC,s ... communities. Since its founding in 1993, PCDC ... primary care area.  PCDC has financed over 100 completed ...
    (Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... August 14. She has accepted the position of vice president of instruction at ... 17. , “I greatly appreciated the opportunity to lead SIUE during the ...
    (Date:6/29/2015)... ... ... This cutting edge standard making is a madatory tool for use in ... is the world’s first cuvette-shaped, solid-state filter that lets metrologists and quality control personnel ... calibration standards, such as those made from didymium glass were only able to operate ...
    (Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... significant CAGR of around 19% during the forecast period (2015 to 2020). The ... and upsurge in government and corporate funding for R&D. However, lack of adequate ...
    Breaking Biology Technology:Custom Computer Specialists Announces Sponsorship Of The Primary Care Development Corporation's Corporate Circle 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 3FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 2FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5
    ... a developer of natural egg protein products, has added $3 ... the closing of its latest financing round, which began on ... funding, collected from various angel investors, will be used by ... that improve feed efficiency and animal growth in agriculture. ...
    ... were to design a system to encourage investment in ... disproportionate number of American jobs, would you do any ... research and development, which has a track record of ... system to the point that it becomes cumbersome and ...
    ... Third Wave Technologies Inc. , a Madison company that ... analysis applications, has named Kay Napier to its board of ... bring marketing insight to Third Wave, according to president and ... and women's markets in the promotion of products at ...
    Cached Biology Technology:aOva Technologies raises $3 million 2Regulations designed to protect 'the little guy' are crimping job growth 2Regulations designed to protect 'the little guy' are crimping job growth 3Napier joins board of Third Wave Technologies 2
    (Date:6/11/2015)... Va. , June 11, 2015 ... technology, announced today that its IdentityX Mobile Authentication ... (Fast IDentity Online) Alliance is an industry consortium ... open standards for simpler, stronger authentication.  In order ... must pass a rigorous series of tests that ...
    (Date:6/9/2015)... , June 9, 2015   MedNet Solutions ... the entire spectrum of clinical research, will be providing ... technology platform at the 2015 Drug Information Association (DIA) ... on June 15-17.  These presentations will include previews of ... out in the upcoming iMedNet 2015 Feature ...
    (Date:6/8/2015)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer of cell-free ... Cancer Monitoring SM platform will be presented at the ... San Diego, CA on June 11-12 , ... Genomics and Cancer Therapy in Salt Lake ... "We continue to advance our clinical programs and present data ...
    Breaking Biology News(10 mins):Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4
    ... of researchers has received a four-year, $1 million grant ... for biological separations. Led by Ravi Kane, the Merck ... Polytechnic Institute, the group plans to develop nanoscale surfaces ... could eventually lead to more efficient separation tools for ...
    ... has named researchers at Baylor College of Medicine (BCM) ... only recipients of the inaugural Quantum Grant for their ... blood vessels for the treatment of stroke. , The ... of Biomedical Imaging and Bioengineering (NIBIB), part of the ...
    ... responds almost like natural heart muscle ?even though it ... another step closer to the goal of creating replacement ... entirely new heart from just a spoonful of loose ... are reporting significant progress in growing bioengineered heart muscle, ...
    Cached Biology News:Researchers to develop active nanoscale surfaces for biological separations 2First Quantum Grant to fund stem cell repair of damage from stroke 2A new approach to growing heart muscle 2A new approach to growing heart muscle 3A new approach to growing heart muscle 4